DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 55 filers reported holding DERMA SCIENCES INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $18,000 | +12.5% | 3,494 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | +14.3% | 3,494 | 0.0% | 0.00% | – |
| Q2 2016 | $14,000 | +16.7% | 3,494 | -10.0% | 0.00% | – |
| Q1 2016 | $12,000 | -33.3% | 3,882 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | 0.0% | 3,882 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -33.3% | 3,882 | +4.5% | 0.00% | – |
| Q2 2015 | $27,000 | -95.8% | 3,714 | -95.1% | 0.00% | -100.0% |
| Q1 2015 | $646,000 | -8.2% | 76,216 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $704,000 | +11.9% | 75,613 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $629,000 | -26.0% | 75,511 | +2.7% | 0.00% | 0.0% |
| Q2 2014 | $850,000 | -2.0% | 73,523 | +7.5% | 0.00% | 0.0% |
| Q1 2014 | $867,000 | +72.4% | 68,388 | +47.1% | 0.00% | 0.0% |
| Q4 2013 | $503,000 | -14.9% | 46,487 | -2.7% | 0.00% | 0.0% |
| Q3 2013 | $591,000 | -4.7% | 47,768 | +2.9% | 0.00% | 0.0% |
| Q2 2013 | $620,000 | – | 46,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
| DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
| Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
| Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
| Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
| HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
| J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
| Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
| Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |